The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
39
No.
24
June 14, 2013Jun 14, 2013
DOWNLOAD THE PDF

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

FASEB: Focus on Research Funding, Not PR

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account